Confirmed Keynotes

Andrew C. von Eschenbach, M.D.
Commissioner of the U.S. Food and Drug Administration

Andrew C. von Eschenbach, M.D., is the Commissioner of the U.S. Food and Drug Administration (FDA) and was formerly the 12th Director of the National Cancer Institute (NCI). A nationally recognized urologic surgeon and oncologist, Dr. von Eschenbach’s distinguished career as a key leader in the fight against cancer spans nearly three decades. Prior to being appointed to lead the NCI in January 2002, Dr. von Eschenbach served as Executive Vice President and Chief Academic Officer of the University of Texas M.D. Anderson Cancer Center in Houston, leading a faculty of more than 1,000 cancer researchers and clinicians. At M.D. Anderson he also served as Vice President for Academic Affairs and held the Roy M. and Phyllis Gough Huffington Clinical Research Distinguished Chair in Urologic Oncology. Dr. von Eschenbach, as founding director of the Prostate Cancer Research Program, was instrumental in fostering integrated research programs in the biology, epidemiology, prevention, and treatment of prostate cancer at M.D. Anderson where he also directed the Genitourinary Cancer Center. He joined M.D. Anderson as a urologic oncology fellow in 1976 and was invited to join the faculty the following year. Just six years later - in 1983 - he was named chairman of the Department of Urology. Other positions held at M.D. Anderson include Consulting Professor of Cell Biology and Professor of Urology.

© Copyright 2007 Wharton Health Care Business Conference